OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In Vivo Tumor-Suppressing and Anti-Angiogenic Activities of a Recombinant Anti-CD3ε Nanobody in Breast Cancer Mice Model
Azadeh Sharif Khatibi, Nasim Hayati Roodbari, Keivan Majidzade-A, et al.
Immunotherapy (2019) Vol. 11, Iss. 18, pp. 1555-1567
Closed Access | Times Cited: 14
Azadeh Sharif Khatibi, Nasim Hayati Roodbari, Keivan Majidzade-A, et al.
Immunotherapy (2019) Vol. 11, Iss. 18, pp. 1555-1567
Closed Access | Times Cited: 14
Showing 14 citing articles:
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
Emily Y. Yang, Khalid Shah
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 250
Emily Y. Yang, Khalid Shah
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 250
Nanobodies in cell-mediated immunotherapy: On the road to fight cancer
Amirhosein Maali, Monireh Gholizadeh, Saba Feghhi-Najafabadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 34
Amirhosein Maali, Monireh Gholizadeh, Saba Feghhi-Najafabadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 34
Computational and Machine Learning Approaches for Optimizing Anti-CD3ε Nanobody: Humanization and Characterization for Enhanced Therapeutic Efficacy
Ali Rahmati Bonab, Hannaneh Jalilzadeh Ghahi, Mahmoud Hassani, et al.
Research Square (Research Square) (2025)
Closed Access
Ali Rahmati Bonab, Hannaneh Jalilzadeh Ghahi, Mahmoud Hassani, et al.
Research Square (Research Square) (2025)
Closed Access
Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications
Charles Shin, Sung Soo Kim, Yong Hwa Jo
Molecular Therapy — Oncolytics (2021) Vol. 22, pp. 166-179
Open Access | Times Cited: 22
Charles Shin, Sung Soo Kim, Yong Hwa Jo
Molecular Therapy — Oncolytics (2021) Vol. 22, pp. 166-179
Open Access | Times Cited: 22
Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 959-1020
Closed Access | Times Cited: 8
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 959-1020
Closed Access | Times Cited: 8
Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
Suad A. K. Shamis, Francesca Savioli, Aula Ammar, et al.
PubMed (2024) Vol. 39, Iss. 2, pp. 177-200
Closed Access | Times Cited: 3
Suad A. K. Shamis, Francesca Savioli, Aula Ammar, et al.
PubMed (2024) Vol. 39, Iss. 2, pp. 177-200
Closed Access | Times Cited: 3
Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancer
Hamid Bakherad, Fahimeh Ghasemi, Maryam Hosseindokht, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Hamid Bakherad, Fahimeh Ghasemi, Maryam Hosseindokht, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model
Hamed Zare, Hamid Bakherad, Arman Nasr Esfahani, et al.
Bioimpacts (2023) Vol. 14, pp. 27829-27829
Open Access | Times Cited: 5
Hamed Zare, Hamid Bakherad, Arman Nasr Esfahani, et al.
Bioimpacts (2023) Vol. 14, pp. 27829-27829
Open Access | Times Cited: 5
Identification and validation of an immune-related gene-based prognostic index for bladder cancer.
Zijian Tian, Lingfeng Meng, Xingbo Long, et al.
PubMed (2020) Vol. 12, Iss. 9, pp. 5188-5204
Closed Access | Times Cited: 11
Zijian Tian, Lingfeng Meng, Xingbo Long, et al.
PubMed (2020) Vol. 12, Iss. 9, pp. 5188-5204
Closed Access | Times Cited: 11
Functionalized nanobody-based delivery systems for cancer diagnosis and therapeutic applications
Govindarajan Venkat Kumar, Amanda‐Lee E. Manicum, Tendai Makwikwi, et al.
Elsevier eBooks (2024), pp. 283-305
Closed Access | Times Cited: 1
Govindarajan Venkat Kumar, Amanda‐Lee E. Manicum, Tendai Makwikwi, et al.
Elsevier eBooks (2024), pp. 283-305
Closed Access | Times Cited: 1
Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates
Alireza Shoari, Mehdi Tahmasebi, Farnaz Khodabakhsh, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108585-108585
Open Access | Times Cited: 6
Alireza Shoari, Mehdi Tahmasebi, Farnaz Khodabakhsh, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108585-108585
Open Access | Times Cited: 6
Engineering Nanobody Targeting Cancer Stem Cells
Md. Sajedul Islam, Vinod Gopalan, Farhadul Islam
(2023), pp. 255-269
Closed Access | Times Cited: 1
Md. Sajedul Islam, Vinod Gopalan, Farhadul Islam
(2023), pp. 255-269
Closed Access | Times Cited: 1
Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma
Qiang He, Shuyin Xue, Qingbiao Wa, et al.
Medicine (2021) Vol. 100, Iss. 17, pp. e25715-e25715
Open Access | Times Cited: 3
Qiang He, Shuyin Xue, Qingbiao Wa, et al.
Medicine (2021) Vol. 100, Iss. 17, pp. e25715-e25715
Open Access | Times Cited: 3
Innovative strategies to study epigenetic regulation and advance precision medicine
Ashley Suris, Yubin Zhou, Yun Huang
Elsevier eBooks (2023), pp. 96-111
Closed Access
Ashley Suris, Yubin Zhou, Yun Huang
Elsevier eBooks (2023), pp. 96-111
Closed Access
